The comparison of muscle strength and short-term endurance in the different periods of type 2 diabetes by Boshra Hatef et al.
Hatef et al. Journal of Diabetes & Metabolic Disorders 2014, 13:22
http://www.jdmdonline.com/content/13/1/22RESEARCH ARTICLE Open AccessThe comparison of muscle strength and short-term
endurance in the different periods of type 2
diabetes
Boshra Hatef1, Farid Bahrpeyma1* and Mohammad R Mohajeri Tehrani2Abstract
Background: Patients with type 2 diabetes (T2DM) are subjected to reduction in the quality and oxidative capacity
of muscles. The effect of duration of diabetes on the muscle endurance response is not clear and strength as well.
Objective: The aim of this study was the assessment of strength and endurance of knee extensor and flexor in the
patients with T2DM < 10 and T2DM > 10 years in comparison with age, sex, BMI, ABI and PAI-matched health
control subjects.
Methods: Isometric maximal peak torque (MPT) of knee extensor and flexor before and after 40 isokinetic
repetitions with velocity of 150 degree/s were recorded in 18 patients with T2DM < 10 Y , 12 patients with T2DM >
10 Y and 20 matched health control (HC) groups.
Results: Both diabetic patient groups had significant lower isometric and isotonic knee extensor and flexor
strength than HC. The endurance indices indicated that whereas the isometric MPT of flexor movement was
reduced after isokinetic protocol in the both patient groups in comparison with HC, the less decline was seen in
the isotonic torque and work during isokinetic protocol in the T2DM > 10 Y group in comparison with two other
groups. The HbA1c and FPG were significantly correlated with strength not with endurance indices.
Conclusions: It seems the progression of diabetes accompanied with vascular, neural and muscular deficits
activate, some adaptive and compensatory processes which can maintain muscle performance.
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Insulin resistance, metabolic inflexibility, muscular and
neuromuscular impairments develop the decrease of
muscle strength and quality especially in the lower limb.
Strength reduction has been associated with increase of
neuropathy, HbA1c and duration of diabetes [1-9]. How-
ever, there are not enough evidences about fatigability of
diabetic muscles [1,5,6,10]. In the study of Andersen et al.,
44 patients with long-term T2DM more than 20 years
were compared with 44 matched health participants. The
results showed that healthy participants were fatigued
more than long-term T2DM during 30 maximal isokinetic
movements of knee and ankle at 180 degree/s was not* Correspondence: bahrpeyf@modares.ac.ir
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reproduction in any medium, provided the orcorrelated neither to the severity of neuropathy nor to the
metabolic control (blood glucose and HbA1c) for any of
the muscle groups [1]. In contrast, two different isokinetic
studies, 20 repetitions with 120 degree/s and 30 repeti-
tions with 180 degree/s, revealed that patients with T2DM
had lower resistance to fatigue in the knee flexor and ex-
tensor in comparison with matched health subjects re-
spectively [5,6]. The distribution and density of muscle
fibers has important role in the fatigue muscle [11]. In the
T2DM patients not only sarcopenia and diminished
muscle quality were observed [7,12] but also the propor-
tion of fatigue-resistant type 1 muscle fiber was decreased
and the proportion of the least fatigue-resistant type 2b
muscle fibers was increased [13-15]. The changes in
muscle fiber distribution are related closely to progress of
diabetes. it is suggested that the increase in the number of
type 2b fibers may be induced by the decrease in thetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mitochondria and oxidative capacity [16], GLUT4 and the
insensitivity to insulin [17]. It is expected in parallel to the
change of muscle type over time, the endurance response
should be changed [11]. But there is no evidence to inves-
tigate the effect of diabetes with different duration on the
endurance property of diabetic muscles. Practically, be-
cause the exercise has important role in the control and
treatment of diabetes, the identification of muscle strength
and endurance properties can be helpful to design the bet-
ter exercise protocol [18]. The assessment of strength and
endurance in the static and dynamic conditions in the
short intensive exercise in the patients with the less and
more than 10 years of diabetes in the comparison with
sex, age, BMI, PAI (physical activity index) and ABI (ankle
brachial index) matched healthy subjects may clarify the




T2DM patients voluntary were recruited by medical
doctors from internal medicine and endocrine clinics of
Tehran. The inclusion criteria were: age between 25-70
years, without any severe or uncontrolled cardiac disease
diagnosed by specialist, no intermittent claudication and
foot ulcers, no muscular disorders or rheumatoid arthritis
and 1.5 > ABI > 0.9. Finally thirty patients participated in
the study and they categorized into two groups according
to the duration of diagnosed diabetes, 18 patients with less
than 10 years of disease in the T2DM< 10 Y group and 12
patients with equal and more than 10 years of disease were
placed in theT2DM> 10 Y group. The healthy control
(HC) group consisted of twenty individuals who were
matched in terms of sex, age, BMI, ABI and PAI with two
other groups. All inclusion criteria and also HbA1c < 6%.
Were considered for HC group written informed consent
was obtained from all participants and the protocol was
approved by the medical ethical committee of the Tarbiat
Modares University.
Procedure
HbA1c and FPG by blood sample and ABI by Doppler
ultrasound in the supine position from dominant leg were
measured in all participants. The ABI is calculated by div-
iding the systolic blood pressure at the ankle by the sys-
tolic blood pressure in the ipsilateral arm the those who
were in normal range between 0.91-1.3 entered the study
[19]. The level of physical activity had been measured by
scoring of PAI [20]. For each person, the total score of
multiplying of exercise intensity and duration and frequency
was calculated and it matched with activity category. All
participants had been distributed in the sedentary, poor and
fair categories.The test for all participants was performed in the after-
noon. The patients were asked to take prescribed medica-
tions. The brachial pressure and finger blood glucose were
measured before test.
Isometric and isokinetic muscle testing
Isometric maximal peak torque [Newton meter] (MPT)
was assessed for the knee flexion and extension of the
dominant leg which determined by the preferred leg for
kicking a ball with an isokinetic dynamometer (HUMAC
NORM, USA). Before the study, all subjects received in-
structions about the procedure and performed a warm-up
session (quadriceps and hamstring stretching 30 second
two times and 5 minutes free load ergonomic cycling and
five trial submaximal repetitions isotonic and two isomet-
ric). After 2 minutes resting, test was started. To deter-
mine maximal voluntary isometric torque, participants
were positioned in a 85 degree of hip and 75 degree of
knee flexion (the optimal length for maximal knee exten-
sor performance [21]), straps were placed around the pel-
vis and trunk. The subject’s knee joint center was aligned
with the rotation center of the dynamometer. The lower
leg was strapped to the dynamometer lever arm resistance
by using a calf pad, 5 cm proximal to the lateral malleolus.
The settings of the chair and lever arm for each subject
were adjusted by calibrations of the instrument. The Ver-
bal encouragement was given during the test and asked
participants to press maximally lever arm to extension for
three times, each press was kept for 3 s and a rest period
of 30 seconds was given between consecutive contractions.
They repeated this protocol for knee flexion as well. Iso-
kinetic protocol (40 isoconcentric knee extension/flexion
performed at 150 degree/s through 0-75 knee flexion) was
followed after a few seconds and the subjects were
instructed to push and pull "as hard and fast as possible"
through the full available ROM at every repetitions without
holding breath and resting. The heart rate was controlled
during the protocol with finger heart beat controller device
attached to the middle finger of the opposite hand. The iso-




The highest torque output from the three MVCs was se-
lected as isometric MPT [21]. The highest torque from
40 repetitions was selected as Isotonic MPT. All joint
moments were normalized by body mass [6]. The ratio
of extensor MPT to flexor was also considered for both
isometric and isotonic records.
The endurance variables
The fatigue index (FI) was calculated as the ratio of the
mean work of the last 5 repetitions to the mean work of
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teen repetitions. The peak torque (PT) of 40 repetitions
were normalized to isotonic MPT and the slope of line
across the relative PT of 40 repetitions was indicated the
amount of force decline during isokinetic protocol. Isomet-
ric MPTs were repeated after isokinetic protocol, then the
different of isometric MPT of extensor, flexor and ratio of
extensor on flexor from those before isokinetic protocol
were also measured. The Table 1 represents all dependent
strength and endurance variables of knee extensor and
flexor torques (Table 1).
Statistical analysis
Chi-squared was used to assess differences of distribution
of sex and PAI and ANOVA was performed to determine
differences of age, weight, length, BMI, ABI, HbAlc, FPG
and glucose test between three groups (HC, T2DM< 10 Y
and T2DM> 10 Y). ANCOVA was carried out to assess
the effect of grouping and sex on the strength indices in
which age was considered as covariate expected the ratio.
Endurance indices were analyzed by two-ways ANOVA in
which grouping and sex were main factors. Pearson correl-
ation was performed to detect correlation between vari-
ables including HbAlc, FPG and glucose test and strength
and endurance indices. A p-value of <0.05 was considered
as significant.Results
We included 18 participated patients with T2DM< 10
years, 12 patients withT2DM> 10 years and 20 HC sub-
jects. Demographic and blood parameters are presented in
Table 2. In general, diabetic subjects with good to moder-
ate blood glucose control included in this study. The HC
group was 10 years younger than T2DM> 10 Y group
(P = 0.02). HbAlc, FPG and glucose test of the HC groupTable 1 Sorting and identification of dependent variables











EXT fatigue index (%) M
FLEX fatigue index (%) M
*WEXT1 and WFLEX1 were MAX isometric torque before 40 isotonic repetitions, WEwas lower than two diabetic groups (P < 0.000) while two
diabetic groups were not different significantly.
Muscle strength
No interaction effect was found between grouping and
sex in the all variables. The HC group had higher iso-
tonic MPT in the EXT and FLEX movements than two
diabetic groups while isometric MPT only in the EXT
movement was higher in the HC group than two dia-
betic groups. Although T2DM> 10 Y group had lower
MPT than T2DM < 10 Y group but the difference was
not significant. All MPT were higher in the men than
women (Table 3). The ratio of MPT EXT on FLEX in
both isometric and isotonic conditions were not been af-
fected by grouping and the isometric ratio of extensor
on flexor was only affected by sex (Figure 1).
Muscle endurance
No interaction effect was found between grouping and sex
in all variables. The Table 4 showed the main effect of
grouping and sex on the endurance indices. The endur-
ance indices of extension movement demonstrated that
no significant different presented between three groups.
Nevertheless The means T2DM> 10 Y group were more
close to means of the HC group in comparison with the
T2DM< 10 Y group (Figure 2). The effect of sex showed
the men had higher EXTFI than women (P = 0.02). It
means the men were more resistant to fatigue in the ex-
tensor muscles than women.
In the flexor movement, the results showed no signifi-
cant effect of gender on endurance indices. The HC
group could kept the isometric MPT of FLEX after iso-
kinetic protocol more than both diabetic groups while
the mean of T2DM > 10 Y group was more close to HC
group. The difference between after and before of iso-
metric MPT ratio showed that the T2DM < 10 Y groupAX torque of EXT isometric/weight
AX torque of FLEX isometric/weight
AX torque of EXT isotonic/weight




he slope of line across the relative isotonic EXT torque of 40 repetitions
he slope of line across the relative isotonic FLEX torque of 40 repetitions
ean 5 last works/mean 5 highest works from 15 first works of EXT
ean 5 last works/mean 5 highest works from 15 first works of FLEX
XT2 and WFLEX2 were MAX isometric torque after 40 isotonic repetitions.
Table 2 Demographic and blood characters
HC T2DM< 10 Y T2DM> 10 Y P value
Number of cases (women/men) 20 (10/10) 18 (9/9) 12 (6/6) 1
Age (years) 49.55 ± 10 52.11 ± 9.2 59.17 ± 7.1 0.02*
Weight (Kg) 73.68 ± 7.7 77.61 ± 12.5 77.72 ± 12.4 0.47
Height (cm) 167.89 ± 9.2 164.33 ± 8.3 166.09 ± 11 0.51
BMI 26.25 ± 3 28.71 ± 4.1 28.54 ± 3.6 0.09
Duration of diabetes (years) 4.8 ± 2 15.5 ± 7
Medication (insulin + drugs/drugs) (N of cases) 1/17 3/9
PAI (sedentary/poor/fair) (%) 63.2, 26.3, 10.5 66.7, 27.8, 5.6 45.5, 54.5,0 0.83
ABI 1.17 ± 0.08 1.22 ± 0.09 1.14 ± 0.14 0.43
HbA1c (%) 4.7 ± 0.8 7.02 ± 1.5 7.3 ± 1.4 0.000
FPG (mmol/l) 91 ± 12.6 141.65 ± 36.9 160.91 ± 31.4 0.000
Blood glucose (mmol/l) 114.05 ± 17.7 167.39 ± 44.23 205.20 ± 84.24 0.000
Data are mean ± SD. *Post Hoc between health and T2DM > 10 Y groups, **Post Hoc between healthy and T2DM > 10 and T2DM <10 Y groups.
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of isokinetic protocol showed that the patients of
T2DM > 10 Y group were more resistant to fatigue than
T2DM < 10 Y group even than HC group that was sig-
nificant only in the FLEX slope. In the three groups the
EXT FI significantly was lower than FLEX FI (P < 0.000)
(Table 4 and Figure 3).
Correlations
HbA1c, FPG and glucose test were correlated negatively
with isotonic MPT of both movement and isometric MPT
of extension movement while only FPG had positive cor-
relation with EXTBA and RATIOBA and negative correl-
ation with FLEXBA from the endurance indices. In the
patients the years of diabetes had significant negative cor-
relation with isotonic MPT of both movement and posi-
tive correlation with slope flex (Table 5).
Discussion
Muscle strength
The hypothesis of the study that the diabetic patients had
weaker muscles than healthy subjects was confirmed. But
there was no significant difference between patients of
T2MD> 10 Y and T2MD< 10 group. It may be because
two patient groups were matched in the PAI, ABI, age,
BMI and sex or limited number of subjects. The ratio of
EXT MPT on the FLEX MPT in the isometric or isotonic
conditions were not affected by diabetes. Most of strength
indices had significant negative correlation with HbA1cTable 3 F and P value of ANCOVA test in the strength indices
T2DM > 10 Y) and sex (men, women)
Main effect of grouping (HC (n = 20), T2DM < 10 Y (n = 18), T2DM > 10 Y (n
Main effect of sex (Men (n = 25), Women (n = 25))
Data are F, Significance of two way ANCOVA. **Post Hoc between HC and T2MD > 1and FPG and glucose test and years of diabetes. The effect
of sex clearly indicated that the men were significantly
stronger than women and there was no interaction effect
of grouping and sex.
The effect of diabetes on the muscle strength specially in
the lower limb strongly has been confirmed in many studies
also correlation of the decrease of strength with the inten-
sity of neuropathy, HbA1c, FPG and duration of diabetes
has been determined [2-7,9,22,23]. The muscle strength is
affected by age, sex and BMI and [24,25]. However, if the
muscle strength is normalized to cross sectional area or
muscle mass detected by DEXA, the gender role would be
reduced [7,26]. Therefore, the study of Ijzerman et al. that
demonstrated lower isometric maximal torque of knee ex-
tension and flexion normalized on the weight in the T2DM
with and without neuropathy than healthy subjects was not
enough reliable because the distribution of gender was sig-
nificantly different between groups [6].
the effect of diabetes duration on the muscle weakness
was investigated by Andersen et al. they observed that the
patients with long-term T2DM more than 20 years had
lower peak isokinetic torque of knee EXT and FLEX than
age, sex and BMI matched control subjects which was re-
lated to the severity of neuropathy while the patients with
diabetes duration less than 10 years had only the signifi-
cant weakness in the FLEX peak torque [2,3]. The 485
T2DM in comparison with 2133 health subjects showed
that the maximal power of knee extensor of diabetic men
was lower than the age and sex matched health subjects,main effect of grouping (HC, T2DM < 10 Y and
WEXT1 WFLEX1 WTEXT WTFLEX
= 12)) 3.99, .026** 2.15, .12 10.57, .000* 8.53, .001*
38.54, .000 69.66, .000 39.04, .000 12.22, .001
0 Y groups, *Post Hoc between HC and T2MD < 10 and >10 Y groups.
Figure 1 Line plots of strength indices in the three groups (HC, T2DM< 10 Y and T2DM> 10 Y) separately in the men and women.
Significance is indicated as*.
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patients which this weakness was correlated with HbA1c
and diabetes duration [7,27]. The decrease of physical activ-
ity also is the important factor to increase muscle weakness
in the T2DM patients [6,28,29]. Based on the previous
studies, the current study has tried to control the effect of
gender, physical activity, BMI, age and peripheral vascular
impairment in the leg by case matching and use the
ANCOVA test to report reliable outcomes as possible.
There are two probable reasons for weakness in the dia-
betes, muscle and neuromuscular impairment. Sarcopenia,
change of fiber distribution, change of GLUT4 density,
mitochondria and intramuscular fat and metabolic inflexibilityTable 4 F and P value of two-way ANOVA of endurance indic
T2DM > 10 Y) and sex (men, women)
Fatigue index Slo
EXT FLEX EXT
Effect of grouping .67, .51 4.05, .050** .30, .73
(HC (n = 20), T2DM < 10 Y (n = 18),
T2DM > 10 Y (n = 12))
Effect of sex 5.60, .02 1.54, .22 1.47, .23
(Men (n = 25), Women (n = 25))
Data are F, Significance of two way ANOVA. **Post Hoc between T2MD < 10 Y and
groups, ¥Post Hoc between HC and two T2MD groups, §: Post Hoc between HC andare mentioned as muscular factors to cause weakness.
Although high percent of these changes are not
dependent to diabetes because it can be seen in the
obesity health subjects and may be related only to insu-
lin resistance [8,12,30,31] but when the diabetic pa-
tients were compared with age, sex and BMI matched
health subjects, the more muscle weakness in the dia-
betic group was observed yet [2,3,7,27]. The second fac-
tor is neuromuscular impairment in the diabetes.
Andreassen et al. found that a down regulation of
neurotropic factors activity such as neurotrophin 3
(NT-3) and neurotrophin 4 (NT-4) released from end
of motor and sympathetic axons to periphery in thees, main effect of grouping (HC, T2DM < 10 Y and
pe Isometric after-before Ratio EXT/FLEX after-before
FLEX EXTBA FLEXBA RatioBA
7.97, .001* .50, .60 11.17, .0001¥ 8.18, .001§
.005, .94 .39, .53 .33, .56 .02, .88
T2MD > 10 Y, *Post Hoc between T2MD > 10 Y and HC and T2MD < 10 Y
T2MD < 10 Y groups.
Figure 2 Line plots are indicated endurance indices in the three groups (HC, T2DM< 10 Y and T2DM> 10 Y).
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cantly more in patients with than without neuropathy
and correlated to gastrocnemius strength [32]. The cor-
relation between the lower limb strength and the inten-
sity of neuropathy has been confirmed in the previous
studies [2,3] by which the second theory is reinforced.
In the current study the isometric MPT of knee flexor
was not enough sensitive to show significant difference
because in the 75 degree of knee flexion, the hamstring
muscle is not in the optimal length to exhibit maximal
effort [33]. The patients were not also classified based
on a standardized clinical neurological examination to
detect the intensity of neuropathy but each patient with-
out any intermittent claudication, foot ulcers and abnor-
mal ABI was included since these symptoms occur in
the advance stage of neuropathy [34].
Muscle endurance
The gender did not significantly effect on endurance in-
dices unless EXT FI in the women who showed more fa-
tigue than men during isokinetic protocol. The diabetes
did not develop influence significantly on the endurance
indices in the extensor versus flexor muscles. FLEXBA
and RATIOBA indicated the HC subjects could sustain
the isometric MPT of knee flexor after isokinetic protocol
better than both diabetic groups. The surprising, FLEX FIand slope, the decline of force during 40 repetitions, was
less in theT2MD > 10 Y group than T2MD< 10 Y and
even HC group and the correlation analysis confirmed
that the increase of years of diabetes correlated with less
negative flexion slope. the result of the current study is ac-
cordance with Andersen et al. which illustrated less de-
cline in endurance index of flexor and extensor of knee
and ankle during 30 repetitions with velocity of 180 de-
gree/s in the 44 T2DM patients with more than 20 years
duration of diabetes in comparison with 44 age, BMI and
physical activity matched health subjects. There was
no significant correlation between endurance index and
HbA1C, blood glucose and the intensity of neuropathy
[1]. The study of IJzerman et al. in which the duration of
diabetes in the patients groups has not been reported,
showed the T2DM without neuropathy had been fatigued
more than HC only in the knee flexor during 20 repeti-
tions isokinetic with velocity of 120 degree/s [6]. It seems
that the different results of two mentioned study may be
related to chronicity of diabetes, since in the current study
that patients were classified based on diabetes duration,
both results were observed. in the our study, some con-
founding factors in the endurance level in the diabetic pa-
tients such as physical activity and peripheral arterial
disease [1] were control in order to achieve reliable out-
comes. Different responses seen in the knee flexor and
Figure 3 Bar plots are indicated mean and SE of EXT and FLEX FI in the three groups (HC, T2DM< 10 Y and T2DM> 10 Y). ** is
indicated significance between EXT and FLEX FI, * is indicated significance between T2DM < 10 Y and T2DM > 10 Y groups.
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muscle fibers and test conditions applied in this study too
[1,6]. The knee flexor and extensor muscles consist of ap-
proximately equal percentage of fast and slow muscle fi-
bers but the percent of slow fibers is dominant in the
quadriceps [35] and fast fibers are dominant in the ham-
string [36,37]. It means the hamstring muscle is less resist-
ance to fatigue but has more glycolytic capacity for
anaerobic activity than quadriceps [11]. Therefore, in dia-
betes which muscle fibers shift to type 2 [13,14], the knee
flexor is susceptible to show significant changes. However,
less loss in flexor muscles effort during isokinetic protocol
observed in this study may be related to the more available
fuel of knee flexors i.e. glycolytic source to compare exten-
sor muscles. On the other hand, regarding to the testTable 5 the correlation of the bloods with muscle factors
WEXT1 WFLEX1 WTEXT W
FPG -.37 (.023) -.10 (.56) -.44 (.007) -.4
HBA1C -.45 (.002) -.17 (.25) -.54 (.000) -.4
Glucose test -.25 (.08) -.16 (.27) -.37 (.008) -.
Years of diabetes -.34 (.06) -.14 (.43) -.44 (.01) -.
Data are Pearson Correlation (P value), n = 50.condition, knee extensor opposed to both the load of mo-
ment arm and gravity while the knee flexor only resisted
to moment arm so the extensor worked more and was
susceptible to more force decline than flexor.
The measurement of isometric MPT as index to assess
the muscle fatigue has not been done up to now. Accumu-
lation of more metabolic substances after isokinetic proto-
col may be responsible for more fatigue in the knee flexor
of the diabetic patients than HC group because all se-
quences of test were anaerobic and dominant source to
apply energy was glycolic [38]. On the other hand, the
level of lactate and pyruvate in the T2DM are higher than
health subjects [39] and one of complication of metformin
therapy is rise of lactate [40]. The type 2 muscle fibers in
which produce greater Phosphocreatine and glycogenTFLEX EXTBA FLEXBA RATIOBA Slope flex
1 (.013) .38 (.02) -.43 (.009) .41 (.013) .17 (.29)
7 (.001) .26 (.08) -.27 (.07) .26 (.07) .14 (.34)
35 (.01) .19 (.19) -.11 (.44) .17 (.22) .30 (.03)
38 (.03) .25 (.17) .27 (.12) -.09 (.62) .61 (.000)
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increase in the diabetes [13,14]. Based on mentioned
topics, we can conclude that the accumulations of meta-
bolic substances such as ADP, PCr and lactate after isokin-
etic protocol in the muscles of diabetic patients greater
than HC group then the force production was more inhib-
ited in the patients. The unexpected result seen in this
study was more isotonic resistance of theT2MD> 10 Y in
comparison with T2MD < 10 Y group which may be ex-
plained as compensatory and adaptive mechanisms related
to develop of diabetes. Several studies confirmed that in
the T2DM the number of type 1 muscle fibers and density
of GLUT4 of slow fibers, number of capillaries around
muscle fiber and oxidative capacity of muscle are de-
creased and the number of type 2B muscle fibers and gly-
colic capacity of muscle are increased [13,14,17,30,42,43].
Oberbach et al indicated that the oxidative and glyco-
lytic enzymes of the all types of muscles fibers and the
density of GLUT4 in the type 2 muscle fiber were in-
creased in the T2DM but the duration of diabetes of pa-
tients was not clear in the study [14]. On the other
hand, the obese health subjects with high waist-to-hip
ratio showed the same abnormalities like diabetic pa-
tients in muscle morphology, namely, a low percentage
of type 1 fibers, elevated type 2 fibers (particularly type
2B) with a low capillary density. But the density of
GLUT4 in both muscle fiber types was reduced more
than the control and diabetic groups. It seems the
changes in the obese subjects were only related to
muscle insulin resistance because of high fat content
[13,17,30]. Changes of the distribution of muscle fibers,
the amount of oxidative and glycolytic enzymes can be af-
fected on the ways to produce energy for muscle actions
and the level of strength and endurance [11,43,44]. Unfor-
tunately, most of the mentioned studies did not report the
duration of diabetes in the patients whereas the duration
of diabetes is main risk factor to progress of vascular and
neural deficits [45,46] and sarcopenia [12,47] then it is ex-
pected that the muscle impairment is to be correlated with
diabetes worsening [4,22,48]. It seems that the increase of
hyperglycemia and insulin resistance result in shifting the
muscle fibers to type 2 which are able to adapt to changes
affected by diabetes [11,16,17,31,43]. Therefore, to com-
pensate loss of type 1 muscle fiber function and preserve
maximal performance, the oxidative and glycolytic cap-
acity of the type 2 muscle fibers gradually will be raised
[14]. Mitochondrial function studies in the progressive
aerobic exercise demonstrated that the T2DM with history
of disease around 6 years exhibited different mitochondria
activity in comparison with patients that had more than
12 years history of disease. The short-term diabetic group
had longer phosphocreatine recovery half time (PCr half-
time) than BMI-matched health group whereas IMCL
(intramyocellular lipid concentration) content was similarwhile the long-term diabetic group had higher IMCL con-
tent with no significant difference in the parameters for
mitochondrial function, i.e. PCr and ADP recovery time
[49,50]. It suggested that compensatory mechanism re-
lated to long-term diabetes in order to increase the muscle
performance might be occurred. As our results showed
the patients with long-term more than 10 years diabetes
had more ability to maintain muscle force during intensive
short repetitive contractions in the postural muscles such
as knee flexor than the T2MD < 10 Y group and was closer
to HC group. Our findings are only attributable to the an-
aerobic condition because the duration of isokinetic proto-
col was around 50 seconds in which the dominant source
of energy is glycolytic system and oxidative circles were
not involved completely [38,41].
Conclusions
It is concluded that patients with long-term diabetes more
than 10 years had more decline in the muscle strength but
less decline in the knee flexor work during intensive short
isokinetic protocol than sex, BMI, ABI and PAI-matched
HC and T2DM< 10 Y groups. It is assumed that generally
the muscular and neuromuscular deficits increase by in-
crease years of disease [4,22] according to increase of
hyperglycemia and insulin resistance but the maturation
of muscle fibers to type 2 has been completed [14] and
glycolic source has been raised. Then the capacity of
muscle to supply energy for short activity is provided even
more than HC group while in early stages of diabetes this
compensation has not been completed. The isometric and
isotonic of strength and endurance indices were lower
than age, sex, BMI, ABI and PAI-matched HC group.
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